Authorized purpose: Ezra Flash is MR image-processing software used to reduce image noise in non-contrast MRI examinations acquired on 3-Tesla Siemens and GE scanners for sagittal T1, axial T2, and axial FLAIR sequences of the head in patients older than 18 years.
Clinical role
Diagnostic magnetic-resonance image acquisition and display, with release-specific reconstruction or derived-image functions where labeled.
Images and patients
MRI · Head
Key limitation
Keep in mind: Use only the exact labeled scanner, field strength, coils, sequences, contrast conditions, patient population, and anatomy; images require trained-physician interpretation.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Ezra Flash is MR image-processing software used to reduce image noise in non-contrast MRI examinations acquired on 3-Tesla Siemens and GE scanners for sagittal T1, axial T2, and axial FLAIR sequences of the head in patients older than 18 years.
Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Head Input: Supported MR acquisitions, pulse sequences, coils, and optional contrast agents within the exact labeled configuration.
Who uses it?Intended users: Appropriately trained healthcare professionals, with image interpretation by a trained physician where stated in the exact labeling.
What does the software produce?Output: Cross-sectional MR images and, where labeled, spectra, parametric maps, dynamic images, or derived physical parameters for professional interpretation.
What is its most important limitation?Key limitation: Use only the exact labeled scanner, field strength, coils, sequences, contrast conditions, patient population, and anatomy; images require trained-physician interpretation.
Clinical takeaway. Clinical role: Ezra Flash is MR image-processing software used to reduce image noise in non-contrast MRI examinations acquired on 3-Tesla Siemens and GE scanners for sagittal T1, axial T2, and axial FLAIR sequences of the head in patients older than 18 years.
Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports software verification, validation, and usability testing, and main performance testing of SNR, CNR and perceived noise (Likert) of Ezra Flash-enhanced versus original MR-acquired images. These are stated in threshold form (SNR on average improved by ≥ 5%, CNR by > 0%, mean Likert result greater than or equal to 0.5 Likert scale points), without measured values or test dataset sizes; the document states the device performs to its intended use. Results are as reported in the FDA submission, not independent validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Ezra Flash is MR image-processing software used to reduce image noise in non-contrast MRI examinations acquired on 3-Tesla Siemens and GE scanners for sagittal T1, axial T2, and axial FLAIR sequences of the head in patients older than 18 years.
Cross-sectional MR images and, where labeled, spectra, parametric maps, dynamic images, or derived physical parameters for professional interpretation.
Use only the exact labeled scanner, field strength, coils, sequences, contrast conditions, patient population, and anatomy; images require trained-physician interpretation.
The exact FDA document reports software verification, validation, and usability testing, and main performance testing of SNR, CNR and perceived noise (Likert) of Ezra Flash-enhanced versus original MR-acquired images. These are stated in threshold form (SNR on average improved by ≥ 5%, CNR by > 0%, mean Likert result greater than or equal to 0.5 Likert scale points), without measured values or test dataset sizes; the document states the device performs to its intended use. Results are as reported in the FDA submission, not independent validation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "evaluated in accordance with design specifications and applicable performance standards through software verification, validation, and usability testing." … "Ezra performed the following main performance testing for Ezra Flash:". Read from the exact FDA decision document on 2026-11-14.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact FDA document reports software verification, validation, and usability testing, and main performance testing of SNR, CNR and perceived noise (Likert) of Ezra Flash-enhanced versus original MR-acquired images. These are stated in threshold form (SNR on average improved by ≥ 5%, CNR by > 0%, mean Likert result greater than or equal to 0.5 Likert scale points), without measured values or test dataset sizes; the document states the device performs to its intended use. Results are as reported in the FDA submission, not independent validation.
FDA source
Exact FDA submission
Checked 2026-11-14
Packet wording: "evaluated in accordance with design specifications and applicable performance standards through software verification, validation, and usability testing." … "Ezra performed the following main performance testing for Ezra Flash:". Read from the exact FDA decision document on 2026-11-14.
No exact-submission and version-linked sensitivity endpoint is promoted; candidate or product-family values were not substituted.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No exact-submission and version-linked specificity endpoint is promoted; candidate or product-family values were not substituted.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
FDA submission-specific verification and validation evidence for K230264
DesignFDA 510(k) regulatory decision material and submission-specific verification or validation evidence for K230264; this is regulatory evidence, not an independent clinical effectiveness study.
PopulationThe labeled population, anatomy, images, and test materials described in the exact FDA decision material for K230264; a broader clinical population is not established here.
Scopeexact submission
Tested versionEzra Flash (K230264)
IndependenceSponsor or vendor study
K230264
The exact FDA material is submission-specific and should not be generalized to other versions, enabled options, sites, protocols, or clinical outcomes.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Supported MR acquisitions, pulse sequences, coils, and optional contrast agents within the exact labeled configuration.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact FDA package describes Ezra Flash receiving DICOM-compliant MR image inputs and outputting a DICOM-compliant copy of the enhanced images, which are viewed on existing PACS workstations. Interface versions and local compatibility require confirmation.
Scope: Exact FDA submission. Packet wording: "Ezra Flash receives DICOM-compliant non-contrast MR image inputs acquired on 3-Tesla" … "The device outputs a DICOM-compliant copy of the images with improved image quality.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes Ezra Flash as a Linux-compatible software package that operates on off-the-shelf hardware with a Linux operating system, the same as the predicate. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "Physical Character- Software package that operates on off- Same istics the-shelf hardware Computer Linux Compatible Same" … "Operating System Linux Same Modalities MRI Same". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Cross-sectional MR images and, where labeled, spectra, parametric maps, dynamic images, or derived physical parameters for professional interpretation.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Cross-sectional MR images and, where labeled, spectra, parametric maps, dynamic images, or derived physical parameters for professional interpretation.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes Ezra Flash as a Linux-compatible software package that operates on off-the-shelf hardware with a Linux operating system, the same as the predicate. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "Physical Character- Software package that operates on off- Same istics the-shelf hardware Computer Linux Compatible Same" … "Operating System Linux Same Modalities MRI Same". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
The exact FDA package describes Ezra Flash receiving DICOM-compliant MR image inputs and outputting a DICOM-compliant copy of the enhanced images, which are viewed on existing PACS workstations. Interface versions and local compatibility require confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "Ezra Flash receives DICOM-compliant non-contrast MR image inputs acquired on 3-Tesla" … "The device outputs a DICOM-compliant copy of the images with improved image quality.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Cross-sectional MR images and, where labeled, spectra, parametric maps, dynamic images, or derived physical parameters for professional interpretation.
exact submission · checked 2026-09-04
Output review, editing, approval, export, and downstream use remain release- and site-specific.
Current vendor material is product-family context for K230264 only; exact release, enabled options, deployment, security, interoperability, pricing, and local workflow require confirmation.
product family · checked 2026-09-04
Vendor material is not exact-release evidence unless that linkage is separately proven.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
31Fields reviewed
13Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, implementation documentation, reimbursement policy, peer reviewed literature, clinical trial registry, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission
No public exact-release price, license fee, subscription, contract, or implementation cost was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not applicable - checked 2026-09-04 - Not applicable
CMS coverage-index context was checked, but no product-specific coverage or reimbursement determination is inferred.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not publicly available - checked 2026-09-04 - Exact FDA submission
Public sources reviewed here do not establish the complete exact-release security posture, including identity, audit, encryption, retention, remote access, vulnerability management, backup, or incident response.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-10-27 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: MICSI-RMT is image-processing software for MRI image enhancement and noise reduction in head MRI images. The FDA material describes analysis of functional and diffusion MRI images and use by radiologists in imaging centers, clinics, or hospitals.
Authorized purpose: The Swoop Portable MR Imaging System is a portable, ultra-low-field, bedside magnetic-resonance device for producing images that display the internal structure of the head where a full diagnostic examination is not clinically practical; a trained physician interprets the images.
Authorized purpose: The Swoop Portable MR Imaging System is a bedside magnetic-resonance device for producing images that display the internal structure of the head where a full diagnostic examination is not clinically practical; a trained physician interprets the images for information useful in determining a diagnosis.
Authorized purpose: The Swoop Portable MR Imaging System is a bedside magnetic-resonance imaging device for producing images that display the internal structure of the head where a full diagnostic examination is not clinically practical; a trained physician interprets the images.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.